oral tirzepatide pill form ODT hormone GLP tirzepatide tablet form DEXA Scan

Glutathione protects and detoxifies them

Purity percentages on COAs are not potency data

The primary outcome was major kidney disease events, a composite of the onset of kidney failure, a sustained 50% reduction in eGFR from baseline, or death from kidney-related or cardiovascular causes

Developed by Eli Lilly as a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, retatrutide achieved a mean body weight reduction of -24.2% at its highest dose over 48 weeks surpassing both semaglutide and tirzepatide in their respective pivotal trials

It contains semaglutide, which plays a key role in weight management, but may cause side effects like Ozempic butt, a phenomenon seen in some users

10.1016/j.tcm.2017.12.003 2